Overview
- Sources told Reuters the company has begun an early-stage process to gauge interest in a sale while keeping other options open.
- Shares rose about 6% Monday on the report before slipping Tuesday, and the stock remains down roughly 55% for 2025.
- Founder Thomas Siebel left the CEO role on Sept. 1 citing an autoimmune disease causing significant visual impairment and now serves as executive chairman.
- New CEO Stephen Ehikian is leading a strategic review after the company withdrew its full-year outlook and reworked sales and services operations.
- C3.ai posted a $116.8 million fiscal first-quarter net loss on a 19% revenue decline to $70.3 million, and it sells enterprise AI software to customers including Shell and the U.S. Air Force.